← Back to work
Works cited by this work
122 works
Work: Pharmacomicrobiomics in blood cancers: How the gut microbiome and its metabolites shape drug efficacy and toxicity
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Dingya Sun, Xin Li, Shengdan Nie +2
Review article20229 citationsABIUnlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies
Ding-Ya Sun, Yijie Hu, Xin Li +3
Review article20247 citationsABIGut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67
Article20176 citationsABIMicrobiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager, Regula Burkhard, Nicola Pett +10
Article20204 citationsABIRole of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
Mengwei Zhang, Jinkai Liu, Qiang Xia
Review article20233 citationsABIAlleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Bret D. Wallace, Hongwei Wang, Kimberly T. Lane +8
Article20103 citationsABIThe Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Ygor Parladore Silva, Andressa Bernardi, Rudimar Luiz Frozza
Review article20203 citationsABIGut microbiota shapes cancer immunotherapy responses
Wanting Lei, Kexun Zhou, Ye Lei +2
Review article20252 citationsABIAssessing the Performance of Prediction Models
Ewout W. Steyerberg, Andrew J. Vickers, Nancy R. Cook +5
Article20092 citationsABIGut microbiome interactions with drug metabolism, efficacy, and toxicity
Ian D. Wilson, Jeremy K. Nicholson
Review article20162 citationsABITargeting A2 adenosine receptors in cancer
David Allard, Martin Turcotte, John Stagg
Review article20172 citationsABI